Dimethoxy docetaxel acetone solvate et method for the preparation thereof

Details for Australian Patent Application No. 2004274212 (hide)

International Classifications

Event Publications

6 April 2006 PCT application entered the National Phase

PCT publication WO2005/028462 Priority application(s): WO2005/028462

4 March 2010 Application Accepted

Published as AU-B-2004274212

1 July 2010 Standard Patent Sealed

28 June 2012 Extension of Term of Standard Patents

Aventis Pharma S.A. The earliest first regulatory approval date provided by the patentee 08 Dec 2011 For the goods JEVTANA cabazitaxel

12 July 2012 Extension of Term of Standard Patents

Aventis Pharma S.A. The earliest first regulatory approval date provided by the patentee 08 Dec 2011 For the goods JEVTANA cabazitaxel Address for service in Australia: Watermark Patent and Trade Marks Attorneys Level 2 302 Burwood Road Hawthorn VIC 3122

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.